Showing results (471-480 of 632) with videos related to
Sort By:
Pageof 64
Urology|December 23, 2008
Phase I-II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radical cystectomy and adjuvant chemotherapyDonald S Kaufman, Kathryn A Winter, William U Shipley, et al.International Journal of Radiation Oncology, Biology, Physics|May 5, 2009
Equivalent biochemical control and improved prostate-specific antigen nadir after permanent prostate seed implant brachytherapy versus high-dose three-dimensional conformal radiotherapy and high-dose conformal proton beam radiotherapy boostSiavash Jabbari, Vivian K Weinberg, Katsuto Shinohara, et al.International Journal of Radiation Oncology, Biology, Physics|July 7, 2009
Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation studyJeff M Michalski, Kyounghwa Bae, Mack Roach, et al.Journal of Psychopharmacology (Oxford, England)|January 28, 2012
Clinical pharmacology of moclobemide, a new reversible monoamine oxidase inhibitorS J Warrington, P Turner, T G Mant, et al.Seminars in Radiation Oncology|April 10, 1999
Optimization and clinical use of multisegment intensity-modulated radiation therapy for high-dose conformal therapyB A Fraass, M L Kessler, D L McShan, et al.International Journal of Radiation Oncology, Biology, Physics|March 1, 1994
Results of primary and adjuvant CT-based 3-dimensional radiotherapy for malignant tumors of the paranasal sinusesW H Roa, M B Hazuka, H M Sandler, et al.Cancer|August 16, 2012
The addition of low-dose-rate brachytherapy and androgen-deprivation therapy decreases biochemical failure and prostate cancer death compared with dose-escalated external-beam radiation therapy for high-risk prostate cancerMark Shilkrut, Gregory S Merrick, P William McLaughlin, et al.Cancer|March 26, 2024
A practical guide for assessing and managing cardiovascular risk during androgen-deprivation therapy in patients with prostate cancerAum J Solanki, Mitchell Kamrava, Edwin M Posadas, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2009
The importance of protein kinase A in prostate cancer: relationship to patient outcome in Radiation Therapy Oncology Group trial 92-02Alan Pollack, Kyounghwa Bae, Li-Yan Khor, et al.Practical Radiation Oncology|June 4, 2014
Patterns of practice in radiation therapy for non-small cell lung cancer among members of the American Society for Radiation OncologyFeng-Ming Spring Kong, Kyle C Cuneo, Li Wang, et al.Pageof 64